Congenital Heart Disease in Children Clinical Trials

9 recruiting

Congenital Heart Disease in Children Trials at a Glance

9 actively recruiting trials for congenital heart disease in children are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Washington D.C., Boston, and Groningen. Lead sponsors running congenital heart disease in children studies include Charite University, Berlin, Germany, Children's Mercy Hospital Kansas City, and Boston Children's Hospital.

Browse congenital heart disease in children trials by phase

Treatments under study

About Congenital Heart Disease in Children Clinical Trials

Looking for clinical trials for Congenital Heart Disease in Children? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Congenital Heart Disease in Children trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Congenital Heart Disease in Children clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 4

Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

Congenital Heart Disease in Children
Phoenix Children's Hospital166 enrolled1 locationNCT04040452
Recruiting

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

Congenital Heart Disease in Children
Boston Children's Hospital10,000 enrolled10 locationsNCT04604418
Recruiting

Evaluation of Preoperative Preparation in Children Undergoing Cardiac Surgery or Catheterization

Congenital Heart Disease in Children
Charite University, Berlin, Germany200 enrolled1 locationNCT07414251
Recruiting

Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.

Congenital Heart SurgeryCongenital Heart Disease in ChildrenFontan Physiology
Martin Schweiger225 enrolled1 locationNCT07029230
Recruiting
Not Applicable

Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease

Neurodevelopmental DisordersCongenital Heart Disease in Children
University Hospital, Montpellier270 enrolled3 locationsNCT06431269
Recruiting
Phase 2Phase 3

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

HypoxiaNeurodevelopmental DisordersCongenital Heart Disease in Children+1 more
University of Utah150 enrolled5 locationsNCT05767385
Recruiting
Not Applicable

Remote Cardiac Rehab for Adolescents With Congenital Heart Disease

Congenital Heart Disease in Children
Children's Mercy Hospital Kansas City74 enrolled1 locationNCT06015191
Recruiting
Phase 3

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

Congenital Heart Disease in ChildrenNeuroprotection
dr. M.J.N.L. Benders236 enrolled4 locationsNCT04217421
Recruiting

Artificial Intelligence-enabled ECG Detection of Congenital Heart Disease in Children: a Novel Diagnostic Tool

Artificial IntelligenceDiagnosisDeep Learning+2 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine30,000 enrolled1 locationNCT06383546